Michel Molier

1.5k total citations
25 papers, 1.1k citations indexed

About

Michel Molier is a scholar working on Infectious Diseases, Molecular Biology and Hepatology. According to data from OpenAlex, Michel Molier has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 7 papers in Molecular Biology and 7 papers in Hepatology. Recurrent topics in Michel Molier's work include Hepatitis Viruses Studies and Epidemiology (7 papers), Liver Disease and Transplantation (6 papers) and Viral gastroenteritis research and epidemiology (5 papers). Michel Molier is often cited by papers focused on Hepatitis Viruses Studies and Epidemiology (7 papers), Liver Disease and Transplantation (6 papers) and Viral gastroenteritis research and epidemiology (5 papers). Michel Molier collaborates with scholars based in Netherlands, Germany and United States. Michel Molier's co-authors include Hans L. Zaaijer, Boris M. Hogema, Ed Slot, Leendert H. J. Looijenga, J. Wolter Oosterhuis, Annelies Riezebos‐Brilman, Carsten Bokemeyer, Anne‐Marie F. Kersemaekers, Pascale C. van Weeren and Jan Trapman and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Michel Molier

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michel Molier Netherlands 16 421 399 301 218 172 25 1.1k
Eric G. Meissner United States 21 666 1.6× 225 0.6× 216 0.7× 51 0.2× 98 0.6× 69 1.3k
Masahiro Onozawa Japan 21 197 0.5× 107 0.3× 398 1.3× 58 0.3× 64 0.4× 109 1.3k
Gustavo Gonzalez-Canali France 17 65 0.2× 406 1.0× 127 0.4× 67 0.3× 36 0.2× 26 1.1k
N Yamaguchi Brazil 8 243 0.6× 55 0.1× 111 0.4× 163 0.7× 26 0.2× 16 815
Anders Bergqvist Sweden 18 113 0.3× 175 0.4× 307 1.0× 68 0.3× 71 0.4× 34 1.1k
A McMichael United Kingdom 18 61 0.1× 79 0.2× 235 0.8× 87 0.4× 127 0.7× 31 1.3k
D E Lewis United States 20 64 0.2× 409 1.0× 242 0.8× 54 0.2× 96 0.6× 32 1.5k
Debbie van Baarle Netherlands 21 158 0.4× 302 0.8× 180 0.6× 58 0.3× 50 0.3× 47 1.3k
Yik Chun Wong Hong Kong 17 385 0.9× 82 0.2× 161 0.5× 488 2.2× 85 0.5× 42 1.1k
Xue–Fan Bai China 20 342 0.8× 403 1.0× 174 0.6× 30 0.1× 61 0.4× 49 1.2k

Countries citing papers authored by Michel Molier

Since Specialization
Citations

This map shows the geographic impact of Michel Molier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Molier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Molier more than expected).

Fields of papers citing papers by Michel Molier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Molier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Molier. The network helps show where Michel Molier may publish in the future.

Co-authorship network of co-authors of Michel Molier

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Molier. A scholar is included among the top collaborators of Michel Molier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Molier. Michel Molier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hogema, Boris M., et al.. (2023). Booster vaccinations and Omicron: the effects on SARS-CoV-2 antibodies in Dutch blood donors. BMC Infectious Diseases. 23(1). 464–464. 2 indexed citations
3.
Slot, Ed, Boris M. Hogema, Chantal Reusken, et al.. (2020). Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands. Nature Communications. 11(1). 5744–5744. 57 indexed citations
4.
Mooij, Sofie H., Boris M. Hogema, Wilfrid van Pelt, et al.. (2018). Risk factors for hepatitis E virus seropositivity in Dutch blood donors. BMC Infectious Diseases. 18(1). 173–173. 26 indexed citations
5.
Slot, Ed, Hans L. Zaaijer, Michel Molier, et al.. (2017). Meat consumption is a major risk factor for hepatitis E virus infection. PLoS ONE. 12(4). e0176414–e0176414. 40 indexed citations
6.
Slot, Ed, Boris M. Hogema, Michel Molier, Aldert Bart, & Hans L. Zaaijer. (2016). Risk Factors and Screening for Trypanosoma cruzi Infection of Dutch Blood Donors. PLoS ONE. 11(3). e0151038–e0151038. 11 indexed citations
7.
Hogema, Boris M., et al.. (2015). Incidence and duration of hepatitis E virus infection in Dutch blood donors. Transfusion. 56(3). 722–728. 87 indexed citations
8.
Koot, Hans M., Boris M. Hogema, M. Koot, Michel Molier, & Hans L. Zaaijer. (2014). Frequent hepatitis E in the Netherlands without traveling or immunosuppression. Journal of Clinical Virology. 62. 38–40. 31 indexed citations
9.
Slot, Ed, et al.. (2013). Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012. Eurosurveillance. 18(31). 175 indexed citations
10.
Hogema, Boris M., Ed Slot, Michel Molier, et al.. (2011). Coxiella burnetii infection among blood donors during the 2009 Q‐fever outbreak in the Netherlands. Transfusion. 52(1). 144–150. 68 indexed citations
11.
Wijngaart, Dennis J. van de, et al.. (2010). Inhibition of androgen receptor functions by gelsolin FxxFF peptide delivered by transfection, cell‐penetrating peptides, and lentiviral infection. The Prostate. 71(3). 241–253. 12 indexed citations
12.
Wijngaart, Dennis J. van de, Michel Molier, Scott J. Lusher, et al.. (2009). Systematic Structure-Function Analysis of Androgen Receptor Leu701 Mutants Explains the Properties of the Prostate Cancer Mutant L701H. Journal of Biological Chemistry. 285(7). 5097–5105. 51 indexed citations
13.
Elfferich, Peter, Achmad Zulfa Juniarto, Hendrikus J. Dubbink, et al.. (2009). Functional Analysis of Novel Androgen Receptor Mutations in a Unique Cohort of Indonesian Patients with a Disorder of Sex Development. Sexual Development. 3(5). 237–244. 7 indexed citations
14.
Hoogerbrugge, Jos W., Martin E. van Royen, Michel Molier, et al.. (2008). A novel mutation F826L in the human androgen receptor in partial androgen insensitivity syndrome; increased NH2-/COOH-terminal domain interaction and TIF2 co-activation. Molecular and Cellular Endocrinology. 292(1-2). 69–78. 12 indexed citations
15.
Dubbink, Hendrikus J., Remko Hersmus, A.C.W. Pike, et al.. (2006). Androgen Receptor Ligand-Binding Domain Interaction and Nuclear Receptor Specificity of FXXLF and LXXLL Motifs as Determined by L/F Swapping. Molecular Endocrinology. 20(8). 1742–1755. 39 indexed citations
16.
Kersemaekers, Anne‐Marie F., Friedemann Honecker, Hans Stoop, et al.. (2005). Identification of germ cells at risk for neoplastic transformation in gonadoblastoma. Human Pathology. 36(5). 512–521. 116 indexed citations
17.
Honecker, Friedemann, Anne‐Marie F. Kersemaekers, Michel Molier, et al.. (2004). Involvement of E‐cadherin and β‐catenin in germ cell tumours and in normal male fetal germ cell development. The Journal of Pathology. 204(2). 167–174. 44 indexed citations
18.
Elstrodt, Fons, Winand N.M. Dinjens, Michel Molier, et al.. (2003). Allelotype of 28 human breast cancer cell lines and xenografts. British Journal of Cancer. 89(12). 2289–2292. 15 indexed citations
19.
Oosterhuis, J. Wolter, Grete Krag Jacobsen, Albertus Timmer, et al.. (2003). Morphology of testicular parenchyma adjacent to germ cell tumours. An interim report. Apmis. 111(1). 32–42. 45 indexed citations
20.
Kersemaekers, Anne‐Marie F., Frank Mayer, Michel Molier, et al.. (2002). Role of P53 and MDM2 in Treatment Response of Human Germ Cell Tumors. Journal of Clinical Oncology. 20(6). 1551–1561. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric G. Meissner Breakdown of academic impact, for papers by Masahiro Onozawa Breakdown of academic impact, for papers by Gustavo Gonzalez-Canali Breakdown of academic impact, for papers by N Yamaguchi Breakdown of academic impact, for papers by Anders Bergqvist Breakdown of academic impact, for papers by A McMichael Breakdown of academic impact, for papers by D E Lewis Breakdown of academic impact, for papers by Debbie van Baarle Breakdown of academic impact, for papers by Yik Chun Wong Breakdown of academic impact, for papers by Xue–Fan Bai
Rankless by CCL
2026